Activation of VDR by vitamin D or a vitamin D analogue interferes with TGF-β signaling and renders CAFs less active, and VDR-mediated manipulation of the tumor stroma has shown promise in enhancing the efficacy of pancreatic cancer therapy [138]. The gene discussed is VDR; the disease is familial pancreatic carcinoma.